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A B S T R A C T
Differentiation of mammalian pluripotent cells involves large-scale changes in transcription and, among the
molecules that orchestrate these changes, chromatin remodellers are essential to initiate, establish and maintain
a new gene regulatory network. The Nucleosome Remodelling and Deacetylation (NuRD) complex is a highly
conserved chromatin remodeller which fine-tunes gene expression in embryonic stem cells. While the function of
NuRD in mouse pluripotent cells has been well defined, no study yet has defined NuRD function in human
pluripotent cells. Here we find that while NuRD activity is required for lineage commitment from primed
pluripotency in both human and mouse cells, the nature of this requirement is surprisingly different. While
mouse embryonic stem cells (mESC) and epiblast stem cells (mEpiSC) require NuRD to maintain an appropriate
differentiation trajectory as judged by gene expression profiling, human induced pluripotent stem cells (hiPSC)
lacking NuRD fail to even initiate these trajectories. Further, while NuRD activity is dispensable for self-renewal
of mESCs and mEpiSCs, hiPSCs require NuRD to maintain a stable self-renewing state. These studies reveal that
failure to properly fine-tune gene expression and/or to reduce transcriptional noise through the action of a
highly conserved chromatin remodeller can have different consequences in human and mouse pluripotent stem
cells.
1. Introduction
The identity of a eukaryotic cell is ultimately determined by its
transcriptional output. The process by which cells transition from one
state to another is therefore necessarily subject to tight transcriptional
controls. For example, during development, in the absence of changes
in external cues, transcriptional programs must remain stable for the
identity of that cell to be maintained. Upon changes in external signals,
transcription of some genes must be downregulated while that of others
must be increased and this results in a change in cellular identity. The
mechanisms which act either to maintain or change the expression state
of a cell therefore underlie the ordered progression of transitions that
occur throughout embryonic development. Failure of regulation of
these gene expression patterns can prevent successful execution of de-
velopmental decisions, leading to developmental abnormalities, tu-
morigenesis or death. A comprehensive understanding of how cells
control transcription during cell fate decisions is therefore critical for
fields where it is desirable to control or instruct cell fate decisions, such
as in regenerative medicine or cancer biology.
The ability of cells to activate or repress transcription relies largely
on the conformation of the chromatin in which these genes reside. A set
of chromatin remodelling complexes function to alter the structure of
chromatin at regulatory elements to control gene expression (Hota and
Bruneau, 2016). One such complex in particular, the NuRD (Nucleo-
some Remodelling and Deacetylation) complex, is important for cells to
undergo the changes in identity associated with the exit from
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pluripotency (Burgold et al., 2019; Kaji et al., 2006; Reynolds et al.,
2012a). The NuRD complex is a highly conserved multiprotein chro-
matin remodeller initially defined as a transcriptional repressor (Tong
et al., 1998; Wade et al., 1998; Xue et al., 1998; Zhang et al., 1998).
NuRD activity facilitates cell fate transitions in a range of different
organisms and developmental contexts (Signolet and Hendrich, 2015).
The complex combines two enzymatic activities: class I lysine deace-
tylation, encoded by the Histone Deacetylase (Hdac) 1 and 2 proteins,
with the Swi/Snf-type ATPase and nucleosome remodelling of the
Chromodomain Helicase DNA binding protein 4 (Chd4). This complex
also contains histone chaperone proteins Rbbp4 and 7, one of the zinc-
finger proteins Gatad2a or Gatad2b, two MTA proteins (Mta1, Mta2,
and/or Mta3), Cdk2ap1 and Mbd2 or Mbd3 (Allen et al., 2013; Kloet
et al., 2015; Mohd-Sarip et al., 2017). Mbd2 and Mbd3 are mutually
exclusive within NuRD and while Mbd2/NuRD can confer methyl-CpG
binding on a variant NuRD complex (aka MeCP1), MBD2 is dispensable
for normal mouse development (Feng and Zhang, 2001; Hendrich et al.,
2001; Le Guezennec et al., 2006). In contrast Mbd3 is known to be
required for lineage commitment of pluripotent cells and is essential for
early mammalian development, demonstrating both that MBD2 cannot
functionally substitute for MBD3 and that MBD3/NuRD is the pre-
dominant NuRD complex in mammalian cells (Hendrich et al., 2001;
Kaji et al., 2006; Kaji et al., 2007). Structural and genetic work has
found that Mbd3 physically links two biochemical and functional NuRD
subcomplexes: a remodelling subcomplex containing Chd4, the Gatad2
protein and Cdk2ap1; and a histone deacetylase subcomplex containing
the Hdac, the Rbbps and the Mta proteins (Burgold et al., 2019; Low
et al., 2016; Zhang et al., 2016). Mbd3 thus acts as a molecular bridge
between these subcomplexes and maintains the structural integrity of
NuRD.
In mouse ESCs (mESCs) Mbd3/NuRD activity modulates the tran-
scription of pluripotency-associated genes, maintaining expression
within a range that allows cells to effectively respond to differentiation
signals (Bornelöv et al., 2018; Reynolds et al., 2012a). In contrast total
NuRD-null mESCs display increased transcriptional noise which ex-
acerbates the lineage commitment defects (Burgold et al., 2019). De-
spite profound developmental defects, Mbd3 deficiency in mESCs re-
sults in only moderate gene expression changes, with the majority of
genes changing by less than two-fold. Rather than turning genes on or
off, Mbd3/NuRD activity serves to fine-tune gene expression in mESCs
(Bornelöv et al., 2018). Although this amounts to many small tran-
scriptional changes, the cumulative effect of this is nevertheless a
profound phenotype: the inability of pluripotent cells to undergo
lineage commitment. While the function of Mbd3/NuRD in mouse
pluripotent cells has been well defined, no study yet has defined NuRD
function in human pluripotent cells.
Human and mouse ESCs can both be derived from the inner cell
mass (ICM) of pre-implantation epiblasts. Yet the cell lines that emerge
after culturing differ in transcriptomic, epigenetic, and morphological
features (Nichols and Smith, 2009). mESCs show early developmental
characteristics such as the expression of pluripotency genes, DNA hy-
pomethylation and the activity of both X chromosomes in females.
Conventional human ESCs (hESCs) are developmentally more advanced
and resemble murine post-implantation epiblast or mouse epiblast stem
cells (mEpiSCs), and thus are considered to be primed pluripotent
(Brons et al., 2007; Tesar et al. 2007). The study of human pluripotent
stem cells has been greatly accelerated by the advent of induced plur-
ipotent stem cells (iPSCs), which are derived from somatic cells and
thus do not require destruction of a human embryo (Nishikawa et al.,
2008; Takahashi and Yamanaka, 2006). As far as can be determined,
human iPSCs show a similar level of potency as human ESCs, but also
show the range of differentiation biases seen in ESCs, possibly due to
differences in culture history, genetic differences between humans,
and/or stochastic changes (Osafune et al., 2008; Yamanaka, 2009). For
this reason, the differences between two ES cell lines, or two iPS lines is
likely to be more significant than any differences between iPS cells and
ES cells per se.
In this study we investigated the function of the MBD3/NuRD
complex in a human iPSC line, and compared this to its function in
mEpiSCs. We find that while MBD3/NuRD is required in both systems
for cells to properly undergo lineage commitment, the way in which
this function is exerted appears different. Whereas in mouse primed
stem cells, as in naïve mESCs, NuRD is required for an appropriate level
of transcriptional response to differentiation signals, human primed
pluripotent cells require NuRD activity to initiate these transcriptional
responses. This difference in the transcriptional consequences upon loss
of an orthologous protein in two different mammalian pluripotent stem
cell types indicates that mouse and human cells interpret and/or re-
spond to induction of differentiation differently.
2. Materials and Methods
2.1. Cell lines and culture conditions
hiPSCs were a generous gift of Prof. Austin Smith (Takashima et al.,
2014). Endogenously tagged MBD3-3xFLAG hiPSCs were made using a
CRISPR/Cas9 gene editing approach to insert 3xFLAG immediately
upstream of the MBD3 stop codon using a guide RNA targeting the
sequence 5′- GAGCGAGTGTAGCACAGGTG-3′ (Supplemental Fig. 1).
MBD3-KO cells were generated by replacing exons 2 and 3 with a
puromycin resistance cassette using CRISPR/Cas9-mediated targeting
and guide RNAs targeting the sequences 5′- GGCGGTGGACCAGCCGC
GCC-3′ and 5′- GTCGCTCTTGACCTTGTTGC-3′. A correctly targeted
heterozygous clone was then transiently transfected with Dre re-
combinase prior to a second round of targeting to generate a homo-
zygous null line (Supplemental Fig. 1). The MBD3 Rescue line was made
by transfecting the MBD3-KO iPS line with a construct containing a
CAG promoter driving expression of full-length MBD3-3xFLAG, fol-
lowed by an IRES and a hygromycin resistance gene, and a polyA se-
quence from the human PGK gene. Hygromycin resistant cells were
expanded and tested for MBD3-3xFLAG expression (e.g. Fig. 2A).
hiPSCs were cultured in mTESR1 (StemCell Technologies) media or
E8 medium (made in house, prepared according to (Chen et al., 2011))
on vitronectin coated plates. hiPSCs were passaged using an enzyme-
free passaging reagent (ReleSR, StemCell Technologies) and plated as
small clumps.
Neuroectoderm differentiation was induced based on (Vallier et al.,
2009). hiPSCs were plated as clumps (day −1) in chemically defined
medium with Polyvinyl Alcohol (CDM-PVA) supplemented with hAc-
tivin A (10 ng/µl) and FGF2 (12 ng/µl) on 0.1% gelatin coated plates
pre-treated overnight at 37 °C with MEF media (Advanced DMEM-F12,
10% FBS, 2 mM L-glutamine, 1× penicillin/streptomycin). The original
composition of CDM is 50% IMDM (Gibco) plus 50% F12 Nutrient-MIX
(Gibco), supplemented with 4 µg/ml of insulin (Roche), 15 µg/ml
transferrin (Roche), 450 µM monothioglycerol (Sigma), chemically
defined lipid concentrate (Invitrogen). The next day (day 0), hiPSCs
were cultured in CDM-PVA supplemented with SB431542 (10 µM, To-
cris), FGF2 (12 ng/ml, R and D Systems) and Noggin (15 ng/ml, Pe-
protech) for 12 additional days. The cells were harvested using Accu-
tase at 3, 6 and 12 days. The media was changed every day.
Definitive endoderm differentiation was induced according to
(Yiangou et al., 2019). Cells were cultured in CDM-PVA supplemented
with 100 ng/ml Activin A (produced in house), 80 ng/ml FGF2 (pro-
duced in house), 10 ng/ml BMP4 (R&D Systems), 10 µM LY294002
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(Promega) and 3uM CHIR99021 for one day, with CHIR99021 omitted
on the second day. From day three onwards, cells were cultured in
RPMI basal medium, supplemented with 100 ng/ml Activin A and
80 ng/ml FGF2 on day 3. From day 4 onwards, RPMI was supplemented
with 50 ng/ml Activin A only. The cells were harvested using Accutase
at days 2, 4, 6 and 8. The media was changed every day.
mEpiSCs were derived from Mbd3Flox/Δ mESCs and subsequently
transiently transfected with Cre recombinase to create Mbd3Δ/Δ cells.
Mbd3Δ/Δ mEpiSCs were independently derived from Mbd3Δ/Δ ES cells.
mEpiSC cultures were maintained in N2B27 supplemented with FGF2
(12 ng/µl), Activin A (20 ng/µl), XAV939 (2 mM, Sigma) on fibronectin
(15 µg/ml) pre-coated plates. The cells were harvested using Accutase
at 2, 4 and 8 days. The media was changed every day. For neural dif-
ferentiation cells were plated on laminin-coated plates in N2B27 con-
taining 1 µM A83-01 (StemMACS).
2.2. Gene expression analysis
This was carried out as described (Burgold et al., 2019). Briefly,
total RNA was isolated using RNA mini easy kit (Qiagen) and reverse
transcribed using random hexamers and Superscript IV Reverse Tran-
scriptase (Invitrogen). Quantitative PCR was carried out using gene-
specific primers and Sybrgreen incorporation, or Taqman reagents on a
















2.3. Nuclear extraction, immunoprecipitation and proteomics
Protein extraction and immunoprecipitation were performed as
described (Burgold et al., 2019). Original western blot images are
available on Mendeley Data: http://dx.doi.org/10.17632/





Dilution for Western Blot/
Immunofluorescence
αCHD4 Mouse Abcam ab70469 1:5000
αGATAD2B Rabbit Bethyl Labs A301-281A 1:2000
αLAMIN B1 Rabbit Abcam ab133741 1:10,000
αMBD3 Rabbit Abcam ab157464 1:5000/1:1000






αβIII Tubulin Mouse Cymbus CBL412 1:1000
Mass spectrometry was carried out as described (Burgold et al., 2019;
Kloet et al., 2018; Smits et al., 2013). Briefly, nuclear extract was
prepared from a human iPS cell line in which a 3xFLAG tag was
knocked in to the endogenous MBD3 locus, or from two independent
mouse epiStem cell lines similarly modified as described (Burgold et al.,
2019). One preparation of nuclear extract from each cell line was di-
vided into thirds, which were independently processed for proteomic
analyses. Proteins associated with 3xFLAG-tagged MBD3 were purified
using anti-FLAG sepharose (Sigma) and processed for mass spectro-
metry as described (Smits et al., 2013). The resulting data were pro-
cessed as in (Kloet et al., 2018).
2.4. RNA-seq and analysis
Sequencing libraries were prepared using the NEXTflex Rapid
Directional RNA-seq kit (Illumina) or SMARTer® Stranded Total RNA-
Seq Kit v2—Pico Input Mammalian (Takara Bio) and sequenced on the
Illumina platform at the CRUK Cambridge Institute Genomics Core fa-
cility (Cambridge, UK). Illumina sequence files were converted into
FASTQ format. The short sequence reads (75 nucleotides) were aligned
to the Human reference genome (hg38; http://genome.ucsc.edu/) or to
the Mouse reference genome (mm10; http://genome.ucsc.edu/) and
assigned to genes using BWA (Li and Durbin, 2009). We used the
Subread package (R statistical tool; http://www.r-project.org/) to
count aligned reads. Differentially expressed genes were identified
using R package edgeR (Chen et al., 2016). We used no fold change
filtering and results were corrected for multi-testing by the method of
the False Discovery Rate (FDR) at the 1% level. Differentially expressed
genes were clustered using the unsupervised classification method of
the Kmeans (Soukas et al., 2000). Heat maps were created using the
pheatmap function (R statistical tool; http://www.r-project.org/).
Functional annotation enrichment for Gene Ontology (GO) terms was
determined using the HumanMine [http://www.humanmine.org]
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(Smith et al., 2012)or MouseMine databases [http://www.mousemine.
org]. Benjamini-Hochberg corrected P values of less than 0.01 were
considered significant. GO terms were submitted to REVIGO, a web
server that takes long lists of GO terms and summarizes them in cate-
gories and clusters of differentially expressed genes by removing re-
dundant entries (Supek et al., 2011). We used the i-cisTarget tool
(Imrichova et al., 2015) to look for enrichment in TF position weight
matrices and potential binding sites in the regulatory regions of co-
expressed genes. i-cisTargetX computes statistical over-representation
of DNA motifs and ChIP-seq peaks in the non-coding DNA around sets of
genes. The enrichment was considered significant when the Normalized
Enrichment Score (NES) was higher than 5.
2.5. Data availability
RNA-seq data are available with the Array Express accession
number E-MTAB-8753. The mass spectrometry proteomics data have
been deposited to the ProteomeXchange Consortium via the PRIDE
partner repository with the dataset identifier PXD016967. All original
western blot images are available at Mendeley Data: DOI: https://
doi.org//10.17632/4t99j4c7gx.1.
3. Results
3.1. NuRD complex structure is conserved in mouse and human pluripotent
stem cells
In order to characterise human NuRD, we used genome editing to
insert coding sequence for a 3xFLAG epitope immediately upstream of
the stop codon of one endogenous MBD3 allele in human iPS cells (Fig.
S1A, B). An equivalent C-terminally tagged murine endogenous MBD3
protein shows genomic localisation identical to that found for wild type
MBD3 protein in mouse ES cells, and supports normal embryonic de-
velopment in mice (Bornelöv et al., 2018). Biochemical isolation of
MBD3/NuRD in MBD3-3xFLAG hiPSCs, or in mEpiSCs containing an
identically modified Mbd3 allele, followed by mass spectrometry iden-
tified all known components of NuRD in both systems (Fig. 1A, B). A
number of interacting proteins were also purified at much lower stoi-
chiometries than was seen for core NuRD components. Comparison of
mass spectrometry data between hiPSCs, mEpiSCs and mouse naïve ES
cells (using MTA1-3 proteins for NuRD purification: (Burgold et al.,
2019)) showed that most interacting proteins identified in human cells
also interact with mouse NuRD (Fig. 1C). Two cell-type specific inter-
actors are VRTN and ZNF423, both of which are not expressed in naïve
ES cells, but are found interacting with NuRD in primed PSCs (mEpiSCs
and hiPSCs; Fig. 1C). Two nuclear proteins were identified interacting
with human NuRD that were not significantly enriched in the mouse
datasets: PGBD3 and BEND3. PGBD3 is a transposase - derived protein
expressed as a fusion with ERCC6 not present in mice (Newman et al.,
2008), but previously reported to interact with NuRD components in
human cells (Hein et al., 2015). Although not significantly detected in
our mouse NuRD purifications, BEND3 has previously been shown to
recruit NuRD to major satellite repeats in mouse cells (Saksouk et al.,
2014). WDR5, ZNF296 and ZNF462 were identified interacting with
mouse NuRD as described (Burgold et al., 2019; Ee et al., 2017; Kloet
et al., 2018), but were beneath our significance cut off in purifications
from human cells (Fig. 1C). We therefore conclude that NuRD structure
and biochemical interactors are generally conserved between mouse
and human PSCs.
3.2. NuRD mutant hiPS cells are unable to maintain a stable pluripotency
state
We next asked what function was played by MBD3/NuRD in human
PSCs. To this end we used CRISPR/Cas9-mediated gene targeting to
create an MBD3-KO iPSC line (Fig. 2A; Fig S1C). Immunoprecipitation
with the remodelling subunit of NuRD, CHD4, allowed for purification
of other complex components in wild type cells, but not in the MBD3-
KO cells, indicating that human NuRD does not form without MBD3
(Fig. 2B). Interactions between CHD4 and other NuRD components
were restored when an MBD3 transgene was overexpressed in the null
cells (“Rescue”, Fig. 2A,B), indicating that the transgenic MBD3 is
sufficient for NuRD formation as it is in mESCs (Bornelöv et al., 2018;
Reynolds et al., 2012b).
MBD3-KO hiPSCs were viable in standard culture conditions
(mTESR or E8 (Chen et al., 2011)), though unlike wild type cells null
cultures showed some degree of spontaneous differentiation in both
culture conditions (Fig. 2C). While wild type and Rescue cultures pre-
sented as morphologically homogeneous colonies with clear bound-
aries, mutant cultures were a mix of cells showing a compact, un-
differentiated morphology as well as a population of flatter, less dense
colonies with irregular boundaries, reminiscent of differentiated cells
(Fig. 2C). This was surprising since Mbd3-KO mESCs are resistant to
differentiation (Kaji et al., 2006).
Wild type, mutant and Rescued hiPSCs were induced to differentiate
towards a neuroectodermal fate or a definitive endoderm fate to de-
termine whether NuRD was required for successful lineage commitment
of human pluripotent cells (see Methods). After 20 days of neuroecto-
dermal differentiation, axon-like extensions were readily identifiable in
wild type and Rescue cultures (Fig. 2C). In contrast, no such appen-
dages were found in MBD3-KO cultures, indicating a requirement for
MBD3/NuRD for successful completion of this differentiation process.
All three cell lines showed a decrease in expression of pluripotency
markers across both differentiation protocols, indicating that NuRD is
not required for PSC to respond to differentiation signals (Fig. 2D, E).
MBD3-KO cells failed to properly induce expression of some lineage-
appropriate genes in both differentiation protocols, but this ability was
restored upon rescue with the MBD3 transgene (Fig. 2D, E). While
NuRD is therefore required in human cells to faithfully maintain a self-
renewing state, it is also required for appropriate lineage determination
in these two differentiation protocols.
To determine how NuRD facilitates lineage commitment in hiPSCs,
we analysed and compared the transcriptomes of WT, MBD3-KO and
Rescue cells at 0, 3, 6 and 12 days upon neuroectodermal differentia-
tion. Visualising the data using a multidimensional scaling plot (Ritchie
et al., 2015) separated each sample along the time of differentiation,
represented by PC1, and the genotype, represented by PC2 (Fig. 3A).
Data from WT and Rescue cells clustered close to each other and fol-
lowed a similar developmental trajectory, indicating that over-
expression of MBD3 does not dramatically impair early stages of neural
differentiation. In contrast, data from MBD3-KO cells clustered sepa-
rately, indicating that they are undergoing aberrant differentiation,
consistent with our RT-qPCR data (Fig. 2D). At day 0 NuRD mutant cells
occupy a position further along the differentiation trajectory (PC1) than
do either WT or Rescue cells, likely resulting from the presence of
morphologically differentiated cells within the self-renewing MBD3-KO
cultures (Fig. 2C).
To try to understand why MBD3-KO PSC were unable to stably
maintain an undifferentiated state, the transcriptomes of WT and
MBD3-KO PSCs were compared in self-renewing conditions (Fig. 3B).
Null cells showed 823 differentially expressed genes compared to wild
type cells (246 up- and 577 down-regulated, FDR 1%). GO term en-
richments performed on the set of down-regulated genes showed terms
related to pluripotency (Fig. 3C, Table S1) consistent with a failure to
maintain a stable pluripotent state in the absence of MBD3/NuRD.
Expression profiles of pluripotency markers (NANOG, TDGF1, FOXD3
and FGF2) showed a significant down-regulation in mutant cultures
when compared to the WT or Rescue cells (Table S1). The 246 up-
regulated genes showed enrichment for terms related to the develop-
ment of different lineages (Fig. 3C, Table S1). Given thatMBD3-KO cells
failed to undergo programmed neural or endodermal differentiation
despite precociously expressing differentiation markers, we conclude
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that, like in mESCs (Burgold et al., 2019), human NuRD functions to
prevent inappropriate gene expression in undifferentiated pluripotent
cells, and this noise reduction function is important for faithful execu-
tion of lineage decisions.
3.3. Human NuRD activity is required for appropriate transcriptional
response to differentiation signals
To better understand how human NuRD facilitates lineage com-
mitment, we next asked how gene expression changes during the dif-
ferentiation time course differed in MBD3-KO cells as compared to WT
or Rescue cells. By considering both genotype and the time of differ-
entiation in our differential analysis, we identified genes showing ex-
pression changes in at least one cell line compared to the others during
differentiation. Clusters of co-expressed genes were identified using K-
means clustering (Li et al., 2018), resulting in 6 groups showing similar
expression profiles (Fig. 4A).
Cluster 1 is composed of 403 genes down-regulated during normal
differentiation (Fig. 4A, B; Tables S2–S4). These genes were generally
underexpressed in MBD3-KO hiPSCs, yet become further down-regu-
lated as cells are subjected to differentiation conditions. This cluster
includes pluripotency-associated genes such as POU5F1, NANOG,
Fig. 1. Comparison of human and mouse NuRD complexes. A) and B). Proteins associated with MBD3/NuRD in hiPSCs (A) or mEpiSCs (B) were identified by
immunoprecipitation and mass spectrometry. Proteins significantly associating with MBD3 are indicated, with NuRD component proteins indicated in red. The
human data comprise three independent immunoprecipitations from one preparation of nuclear extract, while the mouse data comprise three independent im-
munoprecipitations each from nuclear extract preparations made from two independent cell lines. C) Overlap of proteins significantly associating with MBD3 in
hiPSCs, Mbd3 in mEpiSCs, and Mta1, 2 or 3 in mouse ESCs (taken from (Burgold et al., 2019)) is displayed. The numbers in parentheses indicate the number of
significantly enriched proteins in each experiment. D) Relative enrichment of indicated proteins normalised to the bait protein for each experiment: for mouse, ESC
data (a combination of mass spectrometry experiments using Mta1, Mta2 and Mta3 as bait, taken from (Burgold et al., 2019); blue) were normalised to two MTA
proteins, while for both the EpiSC (purple) and hiPSC (red) experiments the data were normalised to one MBD3 protein. Error bars represent standard deviation of
three (hiPSCs), six (mEpiSCs) or nine (mESCs) replicates. Asterisks indicate situations where the protein enrichment was not significant in this cell type, but the
stoichiometry is displayed for comparison. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Fig. 2. Human iPS cells lacking MBD3/NuRD fail to undergo programmed differentiation. A) Western blot of nuclear extracts from wild type (WT), MBD3-KO and
MBD3-KO hiPSCs rescued with an MBD3-3xFLAG transgene (“Rescue”). The blot was probed with antibodies indicated at left. The closed arrowhead indicates native
MBD3, while the open arrowhead indicates the MBD3-3xFLAG fusion protein. B) Nuclear extracts from wild type, MBD3-KO and Rescued cells was im-
munoprecipitated with anti-Chd4, western blotted and probed with antibodies indicated at right. Arrowheads as in Panel A. C) Scheme of the differentiation
experiment (top) and images of indicated cell cultures at Day 0, 7 or 20 of differentiation. Scale bar indicates 100 µm. D) Expression of pluripotency (POU5F1, SOX2
and NANOG) and lineage specific genes (FOXG1, PAX6 and NESTIN) during neural differentiation was measured by qRT-PCR. Y-axis represents expression relative to
that in wild type cells at Day 0, while the X-axis represents the time in days. Error bars represent the standard deviation of ≥3 biological replicates. E) as in panel D,
but for definitive endoderm differentiation protocol. Pluripotency-associated genes (POU5F1, NANOG, ZFP42) on the left, and differentiation-associated genes
(GATA4, FOXA2, SOX17) at right.
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FOXD3, TDGF1, FGF2, ZSCAN10, DPPA4 and PRDM14, validating and
extending our conclusion drawn from data shown in Fig. 3 that MBD3-
KO hiPSCs have a defect in maintaining the self-renewing state in
standard conditions. Transcription factor binding sites enriched within
10 Kb of the TSS of genes in this cluster showed significant enrichment
of consensus binding sites for general transcription factors associated
with activation of pluripotency gene expression (i.e. MYC, ATF, CEBPB;
Table 1), consistent with a decrease in expression of pluripotency-as-
sociated genes. This analysis additionally identified consensus binding
sites for SNAIL and ZEB1 (Table 1), transcription factors associated with
epithelial to mesenchymal transition as well as repression of plur-
ipotency gene expression (Jiang et al., 2018; Moreno-Bueno et al.,
2008). Human ES cells undergo EMT as part of the differentiation
process (Kim et al., 2014), so this likely results from inappropriate
expression of epithelial genes which would normally precede an EMT
event.
Genes in clusters 2–4 are predominantly associated with GO terms
involved in differentiation (Fig. 4B; Tables S2–S4). Cluster 2 contains
genes associated with neuroectodermal differentiation and were in-
duced in wild type and Rescue cells. Cluster 2 genes (including PAX6,
OTX1 and SOX1) showed inappropriate expression in MBD3-KO cells at
time 0 and remained high throughout the differentiation time course.
Cluster 3 genes, some of which are associated with neuronal maturation
(such as PLP1, SEMA3A, and APP) were expressed at a lower level in
mutant cells than in either WT or Rescue cells. Cluster 4 contains genes
not induced in either WT or Rescue cells, but which showed in-
appropriate expression in MBD3-KO cells at all time points (e.g.
WNT5A, FOXA2, PAX7; Fig. 4B, Table S2). Cluster 5 contains only 27
genes which fail to be appropriately silenced during differentiation in
MBD3-KO cells, but show no significant enrichment with any GO term,
and genes in Cluster 6 show similar expression patterns in mutant and
Rescue cells, and are hence unlikely to contribute to the differentiation
Fig. 3. NuRD is required to maintain a stable pluripotency state in hiPSCs A) MDS plot made from RNA-seq data of wild type,MBD3-KO and Rescued hiPSCs across a
neural differentiation timecourse. Each point represents a biological replicate, and shapes indicate the days of differentiation. B) Heat map of genes found to be
differentially expressed between WT andMBD3-KO cells in self-renewing conditions (day 0; FDR 5%). C) GO terms associated with genes significantly activated (open
bars) or repressed (filled bars) in MBD3-KO cells relative to WT hiPSCs in self-renewing conditions.
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Fig. 4. NuRD is required for transcriptional responsiveness in hiPSCs. A) Scheme of the experiment. Wild type (WT), MBD3-KO or Rescued cells maintained in
mTESR1 media were subjected to neural differentiation. Cultures were sampled at indicated time points for RNA-seq, leading to the identification of 1150 annotated
differentially expressed genes (DEG; FDR 1%). Kmeans clustering of genes by expression pattern led to the heat map shown at right, with six major gene clusters. B)
Mean expression for genes in each cluster is displayed across the differentiation time course for each cell line. Error bars indicate standard deviations of average
expression. The four most significant GO terms associated with each cluster are plotted as solid bars, while up to two pathways (P.adj ≤ 0.01) are also plotted in open
bars. A full list of GO terms and pathways is available in Tables S4 and S5.
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failure phenotype of MBD3-KO cells (Fig. S2).
Genes in Clusters 2 and 4 are not associated with any specific TF
binding sites, while Cluster 3 genes show enrichment of binding sites
for the general transcription factor SRF (Table 1). This lack of evidence
for misregulation of a specific transcriptional programme indicates that
MBD3-KO hiPSCs fail to interpret a range of different differentiation
signals, as opposed to just one or two main pathways. The silencing of
pluripotency-associated genes (Cluster 1) in MBD3-KO cells demon-
strates an ability of these cells to respond to the loss of self-renewal
signals, yet the failure of genes in Clusters 2 and 5 to appropriately
change expression during the differentiation time course indicates that
NuRD is required for cells to properly respond to differentiation signals.
3.4. MBD3/NuRD controls lineage commitment differently in human and
mouse primed PSC
Mbd3/NuRD facilitates exit from the self-renewing state in mouse
naïve ESCs (Burgold et al., 2019; Kaji et al., 2006) and thus it was
surprising that human primed PSC required MBD3/NuRD to properly
maintain the self-renewing state. To determine whether this was a
difference between human and mouse cells, or between naïve and
primed pluripotent cells we next asked whether NuRD was required to
maintain the self-renewing state in mEpiSCs. Mbd3−/− mEpiSCs were
derived in culture from Mbd3−/− mESCs or by transient Cre expression
in mEpiSCs derived from Mbd3Flox/- mESCs (See Methods). Mbd3−/−
mEpiSCs derived through either method were indistinguishable, and
appeared uniformly undifferentiated (Fig. 5A, B), indicating that the
spontaneous differentiation seen in hiPSCs does not reflect a general
requirement for MBD3/NuRD to maintain primed PSC.
To further compare mouse and human primed PSC, gene expression
was monitored across a neural differentiation time course in two in-
dependent pairs of Floxed and Mbd3−/− mEpiSCs by RNA-seq (Fig. 5A,
S3; Tables S5–S7) and RT-qPCR (Fig. S4). When the data are visualised
using a multidimensional scaling plot (Chen et al., 2016), each sample
separates along PC1, representing time of differentiation, and PC2, re-
presenting genotype (Fig. 5C). Control and Mbd3−/− cells occupy the
same position along the differentiation trajectory (PC1), consistent with
our observation that mEpiSCs do not require MBD3/NuRD to maintain
a morphologically undifferentiated state.
As with the hiPSCs, we considered both the genotype and the time
of differentiation in our analysis and thus identified 699 differentially
expressed genes. Co-expressed genes were grouped using K-means
clustering, resulting in 4 clusters showing similar expression profiles
(Fig. 5D). In contrast to the human cells which generally showed a lack
of transcriptional response to the differentiation time course, clusters
identified in mouse cells showed transcriptional responses, but these
responses differed from those in wild type cells (Fig. 5E). Cluster 1
genes showed decreased expression in wild type cells across the time
course, but increased expression in Mbd3−/− cells. Genes in clusters 2
and 4 also show increases in both wild type and mutant cells, but
Cluster 2 genes showed a reduced response in mutant cells, whereas
cluster 4 genes showed an increased response. Cluster 3 genes de-
creased in expression in mutant cells across the time course, but showed
no overall change in wild type cells. In all clusters the genes are asso-
ciated with very general GO terms, and are unlikely to represent in-
dividual pathways or developmental trajectories (Fig. 5E; Tables S6 and
S7). These data indicate that in mEpiSC Mbd3/NuRD is not strictly
required for cells to respond to differentiation signals as was seen in
hPSC, but rather is required for an appropriate level of response, as it is
in naïve mESC (Burgold et al., 2019). Rather than being required for the
transcriptional response to differentiation cues as in the human differ-
entiation course, Mbd3/NuRD functions in mouse primed PSC to fa-
cilitate an appropriate transcriptional response to neural induction.
Despite the differences in NuRD-dependent gene regulation ob-
served in mouse and human primed PSC described thus far, we asked
whether there could be a conserved core set of genes regulated similarly
in primed PSC from both species, which might contribute to the shared
requirement for NuRD in lineage commitment. Comparing gene ex-
pression datasets between the human and mouse experiments (Fig. 6A)
identified 153 genes, the orthologues of which were differentially ex-
pressed in both human and mouse cells. K-means clustering of data
from human and mouse cells separately segregated the genes into three
or four main clusters respectively (Fig. 6; Table S8). We next assessed
the impact of MBD3 mutation on the behaviour of clusters which
showed similar expression profiles in WT cells (Fig. 6; Table S9).
Human cluster 1 and mouse cluster 3 were both induced in wild type
cells across the differentiation time course, and were overexpressed in
both cell types at time 0, but in mouse cells these genes showed some
degree of further up-regulation across the time course, whereas there
was no significant increase in expression of these genes in human cells
(Fig. 6B, top). These clusters have only 9 genes in common and return
no significant GO terms (Table S9). The two other comparisons feature
genes associated with general developmental GO terms (Table S9) that
are activated during differentiation (human cluster 2/mouse cluster 4),
or genes which are silenced upon normal differentiation and are asso-
ciated with epithelial development and cell–cell contacts (human
cluster 3/mouse cluster 1; Table S9). In both cases the behaviour of
cluster genes in MBD3-null cells differs in the two species: while human
cluster 2 genes fail to be activated in MBD3-null cells, mouse cluster 4
genes do increase in expression, but to a much lesser extent than in wild
type cells. Human cluster 3 genes are underexpressed in MBD3-null
cells and remain low throughout the differentiation time course, while
mouse cluster 1 genes are expressed at inappropriately high levels in
Mbd3-null mouse cells and remain high during differentiation (Fig. 6).
If, instead of clustering human and mouse genes separately, we ask
whether mouse genes orthologous to those in the human clusters be-
have similarly, we get a similar picture: in general mouse genes do not
behave the same as the human genes (Fig. S6; Tables S9 and S10). We
Table 1
Transcription factor binding sites associated with gene clusters.
Human cluster TF NES score





Cluster 2 NA NA
Cluster 3 SRF 6.06
Cluster 4 NA NA
Cluster 5 NA NA
Cluster 6 TP53 8.07
GFI1B 6.23
Mouse cluster TF NES score






Cluster 2 NA NA
Cluster 3 NA NA
Cluster 4 Trp73 5.05
Overlap cluster TF NES score
Cluster 1 RBBP9 5.33
SF1 5.01




Cluster 3 PSMA6 5.25
SOX6 5.04
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Fig. 5. NuRD facilitates an appropriate transcriptional response in mEpiSCs. A) An outline of the experiment, as in Fig. 4. B) Phase contrast images of wild type or
Mbd3-KO mEpiSCs in self-renewing conditions. C) MDS plot of gene expression data collected across the neural differentiation time course, as in Fig. 3A. D) Heat map
of DEG (FDR 1%) separated into four clusters by K-means clustering. E) Mean expression and most significant GO terms for each cluster as in Fig. 4B. A full list of GO
terms and pathways is available in Tables S6 and S7. Gene expression changes during neural differentiation of an independent pair of WT and Mbd3-KO EpiSCs,
verifying the results of the RNA-seq shown here, is displayed in Fig. S4.
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therefore conclude that the transcriptional consequences of Mbd3/
NuRD loss are different in human versus mouse primed PSC, but in both
cases this activity is required for cells to properly undergo lineage
commitment.
4. Discussion
Differentiation of mammalian pluripotent cells involves large-scale
changes in transcription, which result in loss of one cell identity and
Fig. 6. MBD3/NuRD deficiency elicits a different response in human and mouse primed pluripotent stem cells. A) Schematic of the analysis: the Venn diagram shows
the overlap of differentially expressed genes identified in human cells, and the identified human orthologues of those identified in mEpiSCs. K-means clustering of
this set of 153 genes in human data led to the formation of three gene clusters and to four gene clusters in mouse data. B). Expression profiles are shown for the
different gene clusters. Error bars indicate standard deviations of average expression. Expression profiles of human and mouse gene clusters with similar expression
patterns in wild type cells are displayed together, and the number of common genes is shown. GO terms are available in Table S9.
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gain of a new, more differentiated identity. Orchestrating these changes
in transcription are a large cast of different transcription factors and
signalling molecules, but there is also a set of chromatin remodellers
whose activity is essential to initiate, establish and maintain a new gene
regulatory network (GRN) (Gokbuget and Blelloch, 2019; Hota and
Bruneau, 2016). When induced to differentiate, both mouse and human
pluripotent stem cells depend on NuRD activity to elicit an appropriate
transcriptional response and undergo lineage commitment, but the
manner in which NuRD is used to facilitate this response differs. In-
duction to differentiate elicits changes in transcription from a range of
genes in both human and mouse PSC, though the identity of the specific
genes largely differs in the two species (Fig. 6A). The absence of MBD3/
NuRD activity in human cells results in a subset of these genes failing to
respond to the differentiation cues, while in mutant mouse PSC the
response is present and widespread, but often muted or inappropriate
(Figs. 4 and 5). This subtle difference in NuRD-dependent gene ex-
pression changes could conceivably give rise to quite different down-
streatm consequences, and may underlie the rather low percentage of
genes commonly misregulated during neural differentiation of mouse or
human PSC (Fig. 6A). NuRD activity is additionally required to main-
tain the pluripotency GRN of hiPSCs cultured in self-renewing condi-
tions, but neither primed nor naïve mouse PSCs display this require-
ment (Fig. S3A and (Kaji et al., 2006)). We see no large-scale differences
in the biochemical make-up of NuRD between human and mouse
primed stem cells, which would be consistent with the human and
mouse complexes exerting similar, or identical biochemical functions.
The observed differences in the consequences of MBD3 deficiency are
therefore likely to result from subtle differences in how NuRD activity is
used by the cells to respond to changes in environment.
One example of how human and mouse cells respond differently to
loss of MBD3/NuRD is in regulation of the ZEB1/Zeb1 genes. ZEB1 is
overexpressed in self-renewing human MBD3-/- PSC and remains high
through the neural induction time course, whereas in mouse Mbd3-/-
cells Zeb1 is underexpressed in self-renewing cells and fails to be acti-
vated during the time course (Fig. S5). ZEB1 has been shown to repress
polarity and gap-junction genes associated with an epithelial mor-
phology, promoting an epithelial to mesenchymal transition (EMT)
(Aigner et al., 2007). This function is required for neural differentiation
in vivo and from hESCs in culture (Jiang et al., 2018; Singh et al.,
2016). It is not surprising, then, that Human Cluster 1 genes, which
show underexpression throughout the differentiation time course in
mutant cells and show enrichment for cell adhesion genes
(p = 2 × 10−3; Tables S4 and S5), are also enriched for ZEB1 DNA
binding motifs (Fig. 4B; Table 1). In mouse cells, however, Zeb1 motifs
were associated with the cluster of genes highly associated with cell–-
cell junctions and showing inappropriately high expression levels at all
time points (Cluster 1: Fig. 5D and Table 1), consistent with aberrantly
low expression of the Zeb1 repressor. While transgenic overexpression
of ZEB1 was reported to increase neural differentiation of hESCs (Jiang
et al., 2018), it did not lead to precocious differentiation of self-re-
newing hESCs, and hence is unlikely to be the principal factor behind
the precocious differentiation seen in hiPSCs lacking MBD3.
It is possible that differences in transcriptional responses to differ-
entiation in human and mouse cells could be due to the fact that, unlike
mouse cells, human PSC are unable to maintain a stable self-renewing
state in the absence of MBD3/NuRD, and are, in effect, responding to
loss of self-renewal conditions when they have already started to dif-
ferentiate. One possible, trivial explanation for this difference in the
ability of mouse and human PSC to self-renew could be due to differ-
ences in the constituents of media used for self-renewal culture. Both
mEpiSC culture and hiPSC culture rely on FGF2 and activation of
SMAD2/3 through addition of Activin or TGFβ (Brons et al., 2007; Chen
et al., 2011; Tesar et al., 2007), while naïve mouse ES cells are main-
tained through LIF signalling and dual inhibition of GSK3 and MEK/
ERK (Ying et al., 2008). One consistent difference between mouse and
human PSC culture media is the inclusion in human media of ascorbic
acid (Vitamin C). Ascorbic acid has been shown to increase the activity
of TET enzymes, which promote the demethylation of 5-methylCytosine
in DNA, though this has been shown to promote a more naïve state,
rather than promote differentiation (Blaschke et al., 2013; Yin et al.,
2013). Mbd3-KO mESCs contain a reduced amount of DNA methylation
relative to wild type cells (Latos et al., 2012), consistent with them
being less able to differentiate. It is therefore unlikely that an increase
in TET enzyme activity would be behind the precocious differentiation
seen in hiPSC cultures. Rather, we suggest that the differences observed
between human and mouse PSC in self-renewal or the ability to initiate
an appropriate developmental response are most likely due to differ-
ences between the two species. As pointed out previously (Takashima
et al., 2014), primates have not evolved the ability to undergo em-
bryonic diapause (Nichols and Smith, 2012), and hence pluripotency
may be a less stable state in humans than in mice, and consequently be
less tolerant to the loss of a major chromatin remodelling complex such
as MBD3/NuRD.
The mouse and human NuRD complexes present in primed PSC
appear to be biochemically very similar, and our methods identified no
notable species-specific interactors or alternate stoichiometries (Fig. 1).
By chromatin immunoprecipitation, NuRD is found at all active en-
hancers and promoters in both mouse and human cells (Bornelöv et al.,
2018; Burgold et al., 2019; de Dieuleveult et al., 2016; Gunther et al.,
2013; Miller et al., 2016; Shimbo et al., 2013), but only a relatively
small proportion of these genes changes expression afterMBD3 deletion
(Figs. 4A, 5A) (Bornelöv et al., 2018). This is because NuRD acts to fine-
tune expression through nucleosome mobilisation, and to cement
longer-term gene expression changes through histone deacetylation
activity (Bornelöv et al., 2018; Liang et al., 2017). NuRD’s fine-tuning
function also works to ensure cells are able to respond appropriately
when stem cells are induced to undergo lineage commitment. Yet the
actual series of molecular events through which chromatin remodellers
facilitate a cell’s ability to respond to differentiation cues remain ill-
defined. The rapid development of single molecule and single cell
analyses should allow us to now define exactly how chromatin re-
modellers, signalling molecules and transcription factors all interact at
regulatory sequences to allow cells to respond quickly to changes in the
local environment.
5. Conclusions
NuRD acts to prevent transcriptional ‘noise’ amongst genes that
should be off in pluripotent cells, and it also modulates active tran-
scription. In mouse cells the increased transcriptional noise in the ab-
sence of MBD3/NuRD is tolerated by the cells and they can stably self-
renew, whereas human cells become destabilised by this noise and are
unable to remain in a self-renewing state. When induced to differentiate
the human cells will not be in a homogeneous state and, as a popula-
tion, fail to induce the gene expression programmes necessary for
successful lineage commitment. In contrast the mouse cells remain in a
self-renewing state until induced to differentiate when, although they
can initiate many of the correct gene expression programmes, fail both
to maintain a differentiation trajectory and to commit to a specific
lineage. We propose this difference arises due to a fundamental dif-
ference between mouse and human primed pluripotent cells.
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